Overview
- The report puts Karnataka’s share of India’s bioeconomy at 20.63% and its contribution to state output at 10.51% in 2025.
- The sector expanded from $31.0 billion in 2023 to $39.2 billion in 2025, a cumulative increase of 26.5%.
- Biopharma remains the largest segment with over 40% ($16.44 billion) while bioindustrial biotechnology has surged to $11.46 billion, indicating a shift toward production.
- Deal activity totaled about $1.14 billion across roughly 40 transactions from January 2024 to October 2025 spanning biopharma, medtech, precision fermentation, digital health and agribio.
- Karnataka added 218 biotech startups in 2025 for a total of 1,451, with Bengaluru generating 54% of output as other regions increase their contributions.